DEERFIELD, Ill. July 2, 2008 - Siemens Healthcare Diagnostics received CE marking approval to sell the hepatitis B virus e-antigen (HBeAg) and antibody to the hepatitis B virus (anti-HBe) tests in the European marketplace. More

MALVERN, Pa., June 23, 2008 - The Premier healthcare alliance Purchasing Partners division recently announced that Siemens Healthcare Diagnostics (www.siemens.com/diagnostics) was one of 15 winners chosen for the Pinnacle Award out of more than 800 eligible suppliers, representing the top two percent of healthcare equipment suppliers. More

DEERFIELD, IL. May 8, 2008 - Siemens Healthcare and Laboratory Corporation of America® Holdings (LabCorp®) today announced that they have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. More

Donal Quinn has been appointed new head of the Diagnostics division of the Siemens Healthcare Sector. In his new position, Quinn succeeds Jim Reid-Anderson, who on May 1st became the new CEO of this sector. Prior to his new job, Quinn served as Executive Vice President and Chief Customer Officer of the Diagnostics division since November 2007. More

DEERFIELD, IL., Feb. 18, 2008 ― Siemens Healthcare (www.siemens.com/diagnostics) announced today that its VERSANT™ 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy. More

Deerfield, IL, January 16, 2008  Siemens Healthcare Diagnostics, today announced that it has launched the LOCI® Folate, LOCI® B12, and LOCI® Ferritin tests for use on the Dimension Vista® 1500 Intelligent Lab System, an ultra-integrated chemistry analyzer More

Tarrytown, N.Y., July 31, 2007 – Siemens Medical Solutions Diagnostics, announced today that it has been selected by Amerinet, one of the nation's leading purchasing organizations in the health care industry, to provide a complete line of immunoassay, chemistry, and automation solutions. The agreement meets the needs of Amerinet’s members by offering a diversified product portfolio, tiered pricing schedule, value-added offering, comprehensive menu and rapid turnaround of quality test results. More

Siemens has signed a merger agreement with US-based Dade Behring, Inc., a leading clinical laboratory diagnostics company. Siemens intends to acquire all outstanding shares of Dade Behring by submitting a cash offer to the Dade Behring shareholders of US$77 per common share. The planned acquisition has a total transaction volume of approximately US$7 billion (roughly €5 billion). 
Other press releases and publicly disseminated information can be found by visiting the online USA Press Room at www.usa.siemens.com/medical-pressroom. - Siemens Medical Solutions USA Public Relations More

Tarrytown, N.Y. July 19, 2007 - Siemens Medical Solutions Diagnostics announced today that it has been awarded an agreement with Novation, the healthcare contracting services company of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances to provide chemistry, immunochemistry and automation solutions to VHA, UHC and Healthcare Purchasing Partners International (HPPI) members. This agreement signifies the continued growth between Siemens and Novation and is effective July, 2007. More

Tarrytown, N.Y., July 19, 2007 - Siemens Medical Solutions Diagnostics today announced the introduction of the ADVIA Centaur® Cyclosporine (CsA) assay, an easy to use automated test offering laboratories a highly specific immunoassay for the Cyclosporine A parent compound. More